Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study

Both angiotensin-receptor blockers (ARB) and angiotensin-converting enzyme inhibitors (ACEI) have protective effects against atrial fibrillation (AF). The differences between ARB and ACEI in their effects on the primary prevention of AF remain unclear. This study compared ARB and ACEI in combined an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Medicine (Baltimore)
Autores principales: Hsieh, Yu-Cheng, Hung, Chen-Ying, Li, Cheng-Hung, Liao, Ying-Chieh, Huang, Jin-Long, Lin, Ching-Heng, Wu, Tsu-Juey
Formato: Artigo
Lenguaje:Inglês
Publicado: Wolters Kluwer Health 2016
Materias:
3400
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4902433/
https://ncbi.nlm.nih.gov/pubmed/27196491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000003721
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares